triamcinolone acetonide has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Hayashi, I; Keino, H; Nakayama, M; Okada, AA; Watanabe, T | 1 |
| Hlaing, T; Lei, SL; Tun, KM; Winn, PZ | 1 |
1 review(s) available for triamcinolone acetonide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.
Topics: Adrenal Cortex Hormones; Anosmia; COVID-19; Fluticasone; Humans; Nasal Sprays; Quality of Life; Randomized Controlled Trials as Topic; Steroids; Triamcinolone Acetonide | 2023 |
1 other study(ies) available for triamcinolone acetonide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.
Topics: Aged; COVID-19; Cyclosporine; Glucocorticoids; Humans; Pandemics; Retrospective Studies; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome | 2023 |